Company intelligence / Profile preview

Paradigm4

Waltham, Massachusetts, United Statesparadigm4.com ↗

Ownership: Private
Employees: ~29
Development stage: Other

Overview

Paradigm4’s REVEAL™ platform has been validated by global pharma and biotech companies as foundational to target discovery efforts. The company’s technologies enable rapid integration and analysis of complex multimodal biological datasets at scale to accelerate scientific discovery in life sciences. No clinical results since it does not develop therapeutics.

Modalities: GenomicsProteomicsSingle-cell analysisSmall moleculeBiologicAntibody
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Paradigm4.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paradigm4.

Explore the full profile